We are live on ! Find out more
NVO

Novo Nordisk

1,350 hedge funds and large institutions have $15.6B invested in Novo Nordisk in 2026 Q2 according to their latest regulatory filings, with 215 funds opening new positions, 464 increasing their positions, 459 reducing their positions, and 117 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more first-time investments, than exits

New positions opened: 215 | Existing positions closed: 117

27% more funds holding in top 10

Funds holding in top 10: 1114 (+3)

26% more capital invested

Capital invested by funds: $12.4B → $15.6B (+$3.26B)

6% more funds holding

Funds holding: 1,2771,350 (+73)

1% more repeat investments, than reductions

Existing positions increased: 464 | Existing positions reduced: 459

0.01% more ownership

Funds ownership: 9.62%9.62% (+0.01%)

9% less call options, than puts

Call options by funds: $2.35B | Put options by funds: $2.58B

Holders
1,350
Holders Change
+73
Holders Change %
+5.72%
% of All Funds
16.31%
Holding in Top 10
14
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+27.27%
% of All Funds
0.17%
New
215
Increased
464
Reduced
459
Closed
117
Calls
$2.35B
Puts
$2.58B
Net Calls
-$225M
Net Calls Change
+$475M
Name Holding Trade Value Shares
Change
Change in
Stake
GP
351
Guardian Partners
Canada
$2.36M -$700K -16,298 -25%
PVI
352
Pine Valley Investments
New Jersey
$2.32M +$2.08M +48,469 New
XT
353
XTX Topco
Cayman Islands
$2.32M +$2.08M +48,420 New
AAS
354
Ameritas Advisory Services
Nebraska
$2.32M +$1.17M +27,209 +128%
Capstone Investment Advisors
355
Capstone Investment Advisors
New York
$2.29M -$2.18M -50,768 -52%
Optiver Holding
356
Optiver Holding
Netherlands
$2.29M +$2.05M +47,719 New
HIM
357
Harbour Investment Management
Washington
$2.28M -$3.01K -70 -0.1%
CGH
358
Crossmark Global Holdings
Texas
$2.25M -$290K -6,740 -13%
BFS
359
Bradley Foster & Sargent
Connecticut
$2.25M +$129 +3 +0%
PAS
360
Park Avenue Securities
New York
$2.24M +$192K +4,473 +11%
Allspring Global Investments
361
Allspring Global Investments
North Carolina
$2.22M +$316K +7,349 +19%
SFA
362
Sequoia Financial Advisors
Ohio
$2.21M +$444K +10,339 +29%
BEI
363
Benjamin Edwards Inc
Missouri
$2.19M -$176K -4,106 -8%
OCBCO
364
Oversea-Chinese Banking Corp (OCBC)
Singapore
$2.19M +$231K +5,386 +13%
CG
365
Caprock Group
Idaho
$2.18M +$154K +3,585 +9%
SC
366
Sawyer & Company
Massachusetts
$2.16M
IIA
367
ICW Investment Advisors
Arizona
$2.16M +$12.6K +294 +0.7%
LC
368
Longitude (Cayman)
Cayman Islands
$2.16M +$129K +3,000 +7%
AIC
369
Aurora Investment Counsel
Georgia
$2.13M -$60K -1,397 -3%
PA
370
Pinnacle Associates
New York
$2.12M -$158K -3,688 -8%
CCM
371
Coldstream Capital Management
Washington
$2.11M +$28.5K +663 +2%
JAM
372
JCIC Asset Management
Ontario, Canada
$2.06M
WBCM
373
Wilson & Boucher Capital Management
California
$2.06M -$78.6K -1,830 -4%
1832 Asset Management
374
1832 Asset Management
Ontario, Canada
$2.06M -$136K -3,167 -7%
CGA
375
Channing Global Advisors
Florida
$2.06M +$503K +11,698 +38%

NVO Hedge Fund Activity: Q2 2026 in Review

1,350 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q2 2026, worth a combined $15.6B — up 26% from $12.4B a quarter earlier.

Buyers outnumbered sellers: 215 funds opened new NVO positions and 117 closed out — a net gain of 98 holders — while 464 added to existing stakes and 459 trimmed.

The largest buyer was Fred Alger Management, opening a new position worth an estimated $211M. The largest seller was Susquehanna International Group, cutting an estimated $270M.

  • 1,350 institutional investors held Novo Nordisk (NVO) as of Q2 2026, up from 1,277 in Q1 2026.
  • Funds reported $15.6B of Novo Nordisk stock for Q2 2026, up 26% quarter-over-quarter.
  • 215 funds opened new Novo Nordisk positions in Q2 2026 and 117 closed out, a net change of +98 holders.
  • The largest Novo Nordisk buyer in Q2 2026 was Fred Alger Management, an estimated $211M added.
  • The largest Novo Nordisk seller in Q2 2026 was Susquehanna International Group, an estimated $270M sold.

Based on aggregated 13F filings for Q2 2026.